nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefpodoxime—Cefazolin—PON1—type 2 diabetes mellitus	0.004	0.61	CrCbGaD
Cefpodoxime—Cefradine—CYP3A4—type 2 diabetes mellitus	0.000596	0.0908	CrCbGaD
Cefpodoxime—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000485	0.000488	CcSEcCtD
Cefpodoxime—Rash—Sitagliptin—type 2 diabetes mellitus	0.000484	0.000487	CcSEcCtD
Cefpodoxime—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000483	0.000486	CcSEcCtD
Cefpodoxime—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000483	0.000486	CcSEcCtD
Cefpodoxime—Headache—Glimepiride—type 2 diabetes mellitus	0.000482	0.000485	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000481	0.000485	CcSEcCtD
Cefpodoxime—Cough—Irbesartan—type 2 diabetes mellitus	0.000481	0.000484	CcSEcCtD
Cefpodoxime—Headache—Sitagliptin—type 2 diabetes mellitus	0.000481	0.000484	CcSEcCtD
Cefpodoxime—Anaemia—Losartan—type 2 diabetes mellitus	0.00048	0.000483	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000477	0.00048	CcSEcCtD
Cefpodoxime—Agitation—Losartan—type 2 diabetes mellitus	0.000477	0.00048	CcSEcCtD
Cefpodoxime—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000477	0.00048	CcSEcCtD
Cefpodoxime—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000476	0.000479	CcSEcCtD
Cefpodoxime—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000475	0.000478	CcSEcCtD
Cefpodoxime—Insomnia—Valsartan—type 2 diabetes mellitus	0.000474	0.000477	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000471	0.000474	CcSEcCtD
Cefpodoxime—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00047	0.000473	CcSEcCtD
Cefpodoxime—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00047	0.000473	CcSEcCtD
Cefpodoxime—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000469	0.000472	CcSEcCtD
Cefpodoxime—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000469	0.000472	CcSEcCtD
Cefpodoxime—Shock—Metformin—type 2 diabetes mellitus	0.000469	0.000472	CcSEcCtD
Cefpodoxime—Insomnia—Orlistat—type 2 diabetes mellitus	0.000468	0.000471	CcSEcCtD
Cefpodoxime—Malaise—Losartan—type 2 diabetes mellitus	0.000468	0.000471	CcSEcCtD
Cefpodoxime—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000468	0.000471	CcSEcCtD
Cefpodoxime—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000468	0.000471	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000467	0.00047	CcSEcCtD
Cefpodoxime—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000467	0.00047	CcSEcCtD
Cefpodoxime—Vertigo—Losartan—type 2 diabetes mellitus	0.000466	0.000469	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000466	0.000469	CcSEcCtD
Cefpodoxime—Somnolence—Valsartan—type 2 diabetes mellitus	0.000465	0.000469	CcSEcCtD
Cefpodoxime—Syncope—Losartan—type 2 diabetes mellitus	0.000465	0.000468	CcSEcCtD
Cefpodoxime—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000465	0.000468	CcSEcCtD
Cefpodoxime—Leukopenia—Losartan—type 2 diabetes mellitus	0.000464	0.000468	CcSEcCtD
Cefpodoxime—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000464	0.000467	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000461	0.000464	CcSEcCtD
Cefpodoxime—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000461	0.000464	CcSEcCtD
Cefpodoxime—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000459	0.000462	CcSEcCtD
Cefpodoxime—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000459	0.000462	CcSEcCtD
Cefpodoxime—Palpitations—Losartan—type 2 diabetes mellitus	0.000459	0.000462	CcSEcCtD
Cefpodoxime—Nausea—Glimepiride—type 2 diabetes mellitus	0.000457	0.00046	CcSEcCtD
Cefpodoxime—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000456	0.000459	CcSEcCtD
Cefpodoxime—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000456	0.000459	CcSEcCtD
Cefpodoxime—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000455	0.000458	CcSEcCtD
Cefpodoxime—Asthenia—Glyburide—type 2 diabetes mellitus	0.000455	0.000458	CcSEcCtD
Cefpodoxime—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000455	0.000458	CcSEcCtD
Cefpodoxime—Anorexia—Metformin—type 2 diabetes mellitus	0.000454	0.000457	CcSEcCtD
Cefpodoxime—Cough—Losartan—type 2 diabetes mellitus	0.000453	0.000456	CcSEcCtD
Cefpodoxime—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000453	0.000456	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000452	0.000455	CcSEcCtD
Cefpodoxime—Alopecia—Ramipril—type 2 diabetes mellitus	0.000452	0.000455	CcSEcCtD
Cefpodoxime—Fatigue—Valsartan—type 2 diabetes mellitus	0.000451	0.000454	CcSEcCtD
Cefpodoxime—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000451	0.000453	CcSEcCtD
Cefpodoxime—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000451	0.000453	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00045	0.000453	CcSEcCtD
Cefpodoxime—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.00045	0.000453	CcSEcCtD
Cefpodoxime—Pruritus—Glyburide—type 2 diabetes mellitus	0.000449	0.000452	CcSEcCtD
Cefpodoxime—Constipation—Valsartan—type 2 diabetes mellitus	0.000448	0.000451	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000447	0.00045	CcSEcCtD
Cefpodoxime—Fatigue—Orlistat—type 2 diabetes mellitus	0.000446	0.000449	CcSEcCtD
Cefpodoxime—Hypotension—Metformin—type 2 diabetes mellitus	0.000446	0.000448	CcSEcCtD
Cefpodoxime—Cefazolin—ALB—type 2 diabetes mellitus	0.000445	0.0679	CrCbGaD
Cefpodoxime—Shock—Irbesartan—type 2 diabetes mellitus	0.000443	0.000446	CcSEcCtD
Cefpodoxime—Pain—Orlistat—type 2 diabetes mellitus	0.000442	0.000445	CcSEcCtD
Cefpodoxime—Chest pain—Losartan—type 2 diabetes mellitus	0.000442	0.000445	CcSEcCtD
Cefpodoxime—Myalgia—Losartan—type 2 diabetes mellitus	0.000442	0.000445	CcSEcCtD
Cefpodoxime—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000441	0.000444	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000441	0.000443	CcSEcCtD
Cefpodoxime—Anxiety—Losartan—type 2 diabetes mellitus	0.00044	0.000443	CcSEcCtD
Cefpodoxime—Rash—Bromocriptine—type 2 diabetes mellitus	0.000438	0.000441	CcSEcCtD
Cefpodoxime—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000437	0.00044	CcSEcCtD
Cefpodoxime—Tension—Ramipril—type 2 diabetes mellitus	0.000437	0.000439	CcSEcCtD
Cefpodoxime—Discomfort—Losartan—type 2 diabetes mellitus	0.000436	0.000439	CcSEcCtD
Cefpodoxime—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000436	0.000439	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000435	0.000438	CcSEcCtD
Cefpodoxime—Headache—Bromocriptine—type 2 diabetes mellitus	0.000435	0.000438	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000434	0.000437	CcSEcCtD
Cefpodoxime—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000434	0.000437	CcSEcCtD
Cefpodoxime—Nervousness—Ramipril—type 2 diabetes mellitus	0.000432	0.000435	CcSEcCtD
Cefpodoxime—Dry mouth—Losartan—type 2 diabetes mellitus	0.000432	0.000435	CcSEcCtD
Cefpodoxime—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000429	0.000432	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000428	0.000431	CcSEcCtD
Cefpodoxime—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000428	0.000431	CcSEcCtD
Cefpodoxime—Confusional state—Losartan—type 2 diabetes mellitus	0.000427	0.00043	CcSEcCtD
Cefpodoxime—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000426	0.000429	CcSEcCtD
Cefpodoxime—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000425	0.000428	CcSEcCtD
Cefpodoxime—Somnolence—Metformin—type 2 diabetes mellitus	0.000424	0.000427	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000423	0.000426	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000423	0.000426	CcSEcCtD
Cefpodoxime—Ceftriaxone—ALB—type 2 diabetes mellitus	0.000422	0.0644	CrCbGaD
Cefpodoxime—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00042	0.000423	CcSEcCtD
Cefpodoxime—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00042	0.000423	CcSEcCtD
Cefpodoxime—Dyspepsia—Metformin—type 2 diabetes mellitus	0.00042	0.000422	CcSEcCtD
Cefpodoxime—Tremor—Ramipril—type 2 diabetes mellitus	0.000417	0.00042	CcSEcCtD
Cefpodoxime—Shock—Losartan—type 2 diabetes mellitus	0.000417	0.000419	CcSEcCtD
Cefpodoxime—Urticaria—Valsartan—type 2 diabetes mellitus	0.000416	0.000419	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000415	0.000417	CcSEcCtD
Cefpodoxime—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000414	0.000417	CcSEcCtD
Cefpodoxime—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000414	0.000417	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000413	0.000416	CcSEcCtD
Cefpodoxime—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000412	0.000415	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000412	0.000414	CcSEcCtD
Cefpodoxime—Fatigue—Metformin—type 2 diabetes mellitus	0.000411	0.000414	CcSEcCtD
Cefpodoxime—Urticaria—Orlistat—type 2 diabetes mellitus	0.000411	0.000414	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.00041	0.000413	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000409	0.000412	CcSEcCtD
Cefpodoxime—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000409	0.000412	CcSEcCtD
Cefpodoxime—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000409	0.000412	CcSEcCtD
Cefpodoxime—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000409	0.000412	CcSEcCtD
Cefpodoxime—Agitation—Ramipril—type 2 diabetes mellitus	0.000409	0.000412	CcSEcCtD
Cefpodoxime—Constipation—Metformin—type 2 diabetes mellitus	0.000408	0.00041	CcSEcCtD
Cefpodoxime—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000404	0.000407	CcSEcCtD
Cefpodoxime—Anorexia—Losartan—type 2 diabetes mellitus	0.000404	0.000406	CcSEcCtD
Cefpodoxime—Vomiting—Glyburide—type 2 diabetes mellitus	0.000404	0.000406	CcSEcCtD
Cefpodoxime—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000403	0.000406	CcSEcCtD
Cefpodoxime—Malaise—Ramipril—type 2 diabetes mellitus	0.000401	0.000404	CcSEcCtD
Cefpodoxime—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000401	0.000404	CcSEcCtD
Cefpodoxime—Rash—Glyburide—type 2 diabetes mellitus	0.0004	0.000403	CcSEcCtD
Cefpodoxime—Somnolence—Irbesartan—type 2 diabetes mellitus	0.0004	0.000403	CcSEcCtD
Cefpodoxime—Dermatitis—Glyburide—type 2 diabetes mellitus	0.0004	0.000402	CcSEcCtD
Cefpodoxime—Vertigo—Ramipril—type 2 diabetes mellitus	0.0004	0.000402	CcSEcCtD
Cefpodoxime—Syncope—Ramipril—type 2 diabetes mellitus	0.000399	0.000402	CcSEcCtD
Cefpodoxime—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000398	0.000401	CcSEcCtD
Cefpodoxime—Headache—Glyburide—type 2 diabetes mellitus	0.000398	0.0004	CcSEcCtD
Cefpodoxime—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000396	0.000399	CcSEcCtD
Cefpodoxime—Hypotension—Losartan—type 2 diabetes mellitus	0.000396	0.000398	CcSEcCtD
Cefpodoxime—Palpitations—Ramipril—type 2 diabetes mellitus	0.000393	0.000396	CcSEcCtD
Cefpodoxime—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000393	0.000396	CcSEcCtD
Cefpodoxime—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000391	0.000394	CcSEcCtD
Cefpodoxime—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000391	0.000394	CcSEcCtD
Cefpodoxime—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00039	0.000392	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00039	0.000392	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000388	0.000391	CcSEcCtD
Cefpodoxime—Cough—Ramipril—type 2 diabetes mellitus	0.000388	0.000391	CcSEcCtD
Cefpodoxime—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000388	0.00039	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000386	0.000388	CcSEcCtD
Cefpodoxime—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000386	0.000388	CcSEcCtD
Cefpodoxime—Convulsion—Ramipril—type 2 diabetes mellitus	0.000385	0.000388	CcSEcCtD
Cefpodoxime—Cephalexin—CYP3A4—type 2 diabetes mellitus	0.000385	0.0588	CrCbGaD
Cefpodoxime—Pain—Irbesartan—type 2 diabetes mellitus	0.000385	0.000387	CcSEcCtD
Cefpodoxime—Constipation—Irbesartan—type 2 diabetes mellitus	0.000385	0.000387	CcSEcCtD
Cefpodoxime—Insomnia—Losartan—type 2 diabetes mellitus	0.000383	0.000386	CcSEcCtD
Cefpodoxime—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000381	0.000384	CcSEcCtD
Cefpodoxime—Paraesthesia—Losartan—type 2 diabetes mellitus	0.00038	0.000383	CcSEcCtD
Cefpodoxime—Urticaria—Metformin—type 2 diabetes mellitus	0.000379	0.000381	CcSEcCtD
Cefpodoxime—Myalgia—Ramipril—type 2 diabetes mellitus	0.000379	0.000381	CcSEcCtD
Cefpodoxime—Chest pain—Ramipril—type 2 diabetes mellitus	0.000379	0.000381	CcSEcCtD
Cefpodoxime—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000378	0.00038	CcSEcCtD
Cefpodoxime—Anxiety—Ramipril—type 2 diabetes mellitus	0.000377	0.00038	CcSEcCtD
Cefpodoxime—Nausea—Glyburide—type 2 diabetes mellitus	0.000377	0.000379	CcSEcCtD
Cefpodoxime—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000377	0.000379	CcSEcCtD
Cefpodoxime—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000377	0.000379	CcSEcCtD
Cefpodoxime—Somnolence—Losartan—type 2 diabetes mellitus	0.000376	0.000379	CcSEcCtD
Cefpodoxime—Asthenia—Valsartan—type 2 diabetes mellitus	0.000376	0.000378	CcSEcCtD
Cefpodoxime—Discomfort—Ramipril—type 2 diabetes mellitus	0.000374	0.000377	CcSEcCtD
Cefpodoxime—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000373	0.000375	CcSEcCtD
Cefpodoxime—Asthenia—Orlistat—type 2 diabetes mellitus	0.000371	0.000374	CcSEcCtD
Cefpodoxime—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000371	0.000373	CcSEcCtD
Cefpodoxime—Pruritus—Valsartan—type 2 diabetes mellitus	0.00037	0.000373	CcSEcCtD
Cefpodoxime—Dry mouth—Ramipril—type 2 diabetes mellitus	0.00037	0.000373	CcSEcCtD
Cefpodoxime—Cefalotin—ALB—type 2 diabetes mellitus	0.00037	0.0564	CrCbGaD
Cefpodoxime—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000368	0.000371	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000368	0.00037	CcSEcCtD
Cefpodoxime—Confusional state—Ramipril—type 2 diabetes mellitus	0.000366	0.000369	CcSEcCtD
Cefpodoxime—Pruritus—Orlistat—type 2 diabetes mellitus	0.000366	0.000368	CcSEcCtD
Cefpodoxime—Fatigue—Losartan—type 2 diabetes mellitus	0.000365	0.000367	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000363	0.000365	CcSEcCtD
Cefpodoxime—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000362	0.000365	CcSEcCtD
Cefpodoxime—Pain—Losartan—type 2 diabetes mellitus	0.000362	0.000365	CcSEcCtD
Cefpodoxime—Constipation—Losartan—type 2 diabetes mellitus	0.000362	0.000365	CcSEcCtD
Cefpodoxime—Rash—Gliclazide—type 2 diabetes mellitus	0.000359	0.000362	CcSEcCtD
Cefpodoxime—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000359	0.000361	CcSEcCtD
Cefpodoxime—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000358	0.000361	CcSEcCtD
Cefpodoxime—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000357	0.00036	CcSEcCtD
Cefpodoxime—Shock—Ramipril—type 2 diabetes mellitus	0.000357	0.00036	CcSEcCtD
Cefpodoxime—Headache—Gliclazide—type 2 diabetes mellitus	0.000357	0.000359	CcSEcCtD
Cefpodoxime—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000356	0.000358	CcSEcCtD
Cefpodoxime—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000356	0.000358	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000356	0.000358	CcSEcCtD
Cefpodoxime—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000354	0.000356	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000351	0.000353	CcSEcCtD
Cefpodoxime—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000349	0.000351	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000346	0.000349	CcSEcCtD
Cefpodoxime—Dizziness—Valsartan—type 2 diabetes mellitus	0.000346	0.000349	CcSEcCtD
Cefpodoxime—Anorexia—Ramipril—type 2 diabetes mellitus	0.000346	0.000348	CcSEcCtD
Cefpodoxime—Dizziness—Orlistat—type 2 diabetes mellitus	0.000342	0.000344	CcSEcCtD
Cefpodoxime—Asthenia—Metformin—type 2 diabetes mellitus	0.000342	0.000344	CcSEcCtD
Cefpodoxime—Hypotension—Ramipril—type 2 diabetes mellitus	0.000339	0.000342	CcSEcCtD
Cefpodoxime—Nausea—Gliclazide—type 2 diabetes mellitus	0.000339	0.000341	CcSEcCtD
Cefpodoxime—Pruritus—Metformin—type 2 diabetes mellitus	0.000337	0.00034	CcSEcCtD
Cefpodoxime—Urticaria—Losartan—type 2 diabetes mellitus	0.000336	0.000339	CcSEcCtD
Cefpodoxime—Cephalexin—ALB—type 2 diabetes mellitus	0.000336	0.0513	CrCbGaD
Cefpodoxime—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000335	0.000337	CcSEcCtD
Cefpodoxime—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000335	0.000337	CcSEcCtD
Cefpodoxime—Vomiting—Valsartan—type 2 diabetes mellitus	0.000333	0.000335	CcSEcCtD
Cefpodoxime—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000332	0.000334	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000331	0.000333	CcSEcCtD
Cefpodoxime—Rash—Valsartan—type 2 diabetes mellitus	0.00033	0.000332	CcSEcCtD
Cefpodoxime—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00033	0.000332	CcSEcCtD
Cefpodoxime—Vomiting—Orlistat—type 2 diabetes mellitus	0.000329	0.000331	CcSEcCtD
Cefpodoxime—Insomnia—Ramipril—type 2 diabetes mellitus	0.000328	0.000331	CcSEcCtD
Cefpodoxime—Headache—Valsartan—type 2 diabetes mellitus	0.000328	0.00033	CcSEcCtD
Cefpodoxime—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000326	0.000328	CcSEcCtD
Cefpodoxime—Rash—Orlistat—type 2 diabetes mellitus	0.000326	0.000328	CcSEcCtD
Cefpodoxime—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000326	0.000328	CcSEcCtD
Cefpodoxime—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000326	0.000328	CcSEcCtD
Cefpodoxime—Headache—Orlistat—type 2 diabetes mellitus	0.000324	0.000326	CcSEcCtD
Cefpodoxime—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000324	0.000326	CcSEcCtD
Cefpodoxime—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000323	0.000325	CcSEcCtD
Cefpodoxime—Somnolence—Ramipril—type 2 diabetes mellitus	0.000323	0.000325	CcSEcCtD
Cefpodoxime—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.00032	0.000322	CcSEcCtD
Cefpodoxime—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000318	0.00032	CcSEcCtD
Cefpodoxime—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000316	0.000318	CcSEcCtD
Cefpodoxime—Dizziness—Metformin—type 2 diabetes mellitus	0.000315	0.000317	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000313	0.000316	CcSEcCtD
Cefpodoxime—Fatigue—Ramipril—type 2 diabetes mellitus	0.000313	0.000315	CcSEcCtD
Cefpodoxime—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000312	0.000314	CcSEcCtD
Cefpodoxime—Nausea—Valsartan—type 2 diabetes mellitus	0.000311	0.000313	CcSEcCtD
Cefpodoxime—Constipation—Ramipril—type 2 diabetes mellitus	0.000311	0.000313	CcSEcCtD
Cefpodoxime—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000308	0.00031	CcSEcCtD
Cefpodoxime—Nausea—Orlistat—type 2 diabetes mellitus	0.000307	0.000309	CcSEcCtD
Cefpodoxime—Asthenia—Losartan—type 2 diabetes mellitus	0.000304	0.000306	CcSEcCtD
Cefpodoxime—Vomiting—Metformin—type 2 diabetes mellitus	0.000303	0.000305	CcSEcCtD
Cefpodoxime—Rash—Metformin—type 2 diabetes mellitus	0.000301	0.000303	CcSEcCtD
Cefpodoxime—Dermatitis—Metformin—type 2 diabetes mellitus	0.0003	0.000302	CcSEcCtD
Cefpodoxime—Pruritus—Losartan—type 2 diabetes mellitus	0.0003	0.000302	CcSEcCtD
Cefpodoxime—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000299	0.000301	CcSEcCtD
Cefpodoxime—Headache—Metformin—type 2 diabetes mellitus	0.000299	0.000301	CcSEcCtD
Cefpodoxime—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000298	0.0003	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000297	0.000299	CcSEcCtD
Cefpodoxime—Diarrhoea—Losartan—type 2 diabetes mellitus	0.00029	0.000292	CcSEcCtD
Cefpodoxime—Urticaria—Ramipril—type 2 diabetes mellitus	0.000288	0.00029	CcSEcCtD
Cefpodoxime—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000287	0.000289	CcSEcCtD
Cefpodoxime—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000287	0.000289	CcSEcCtD
Cefpodoxime—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000286	0.000288	CcSEcCtD
Cefpodoxime—Rash—Irbesartan—type 2 diabetes mellitus	0.000284	0.000286	CcSEcCtD
Cefpodoxime—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000283	0.000285	CcSEcCtD
Cefpodoxime—Nausea—Metformin—type 2 diabetes mellitus	0.000283	0.000285	CcSEcCtD
Cefpodoxime—Headache—Irbesartan—type 2 diabetes mellitus	0.000282	0.000284	CcSEcCtD
Cefpodoxime—Dizziness—Losartan—type 2 diabetes mellitus	0.00028	0.000282	CcSEcCtD
Cefpodoxime—Vomiting—Losartan—type 2 diabetes mellitus	0.000269	0.000271	CcSEcCtD
Cefpodoxime—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000268	0.000269	CcSEcCtD
Cefpodoxime—Nausea—Irbesartan—type 2 diabetes mellitus	0.000267	0.000269	CcSEcCtD
Cefpodoxime—Rash—Losartan—type 2 diabetes mellitus	0.000267	0.000269	CcSEcCtD
Cefpodoxime—Dermatitis—Losartan—type 2 diabetes mellitus	0.000267	0.000269	CcSEcCtD
Cefpodoxime—Headache—Losartan—type 2 diabetes mellitus	0.000265	0.000267	CcSEcCtD
Cefpodoxime—Asthenia—Ramipril—type 2 diabetes mellitus	0.000261	0.000262	CcSEcCtD
Cefpodoxime—Pruritus—Ramipril—type 2 diabetes mellitus	0.000257	0.000259	CcSEcCtD
Cefpodoxime—Nausea—Losartan—type 2 diabetes mellitus	0.000252	0.000253	CcSEcCtD
Cefpodoxime—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000248	0.00025	CcSEcCtD
Cefpodoxime—Dizziness—Ramipril—type 2 diabetes mellitus	0.00024	0.000242	CcSEcCtD
Cefpodoxime—Vomiting—Ramipril—type 2 diabetes mellitus	0.000231	0.000232	CcSEcCtD
Cefpodoxime—Rash—Ramipril—type 2 diabetes mellitus	0.000229	0.00023	CcSEcCtD
Cefpodoxime—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000229	0.00023	CcSEcCtD
Cefpodoxime—Headache—Ramipril—type 2 diabetes mellitus	0.000227	0.000229	CcSEcCtD
Cefpodoxime—Nausea—Ramipril—type 2 diabetes mellitus	0.000216	0.000217	CcSEcCtD
